Biblio print

Tree Display

AceDB Schema

XML Display


Author Report for: Jones RW

No contact information in database for Jones RW

    Title: Souvenaid(R): a new approach to management of early Alzheimer's disease
    Ritchie CW, Bajwa J, Coleman G, Hope K, Jones RW, Lawton M, Marven M, Passmore P
    Ref: J Nutr Health Aging, 18:291, 2014 : PubMed


    Title: Trends in the prevalence of antipsychotic drug use among patients with Alzheimer's disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study
    Martinez C, Jones RW, Rietbrock S
    Ref: BMJ Open, 3:, 2013 : PubMed


    Title: Rationale for combining glutamatergic and cholinergic approaches in the symptomatic treatment of Alzheimer's disease
    Francis PT, Parsons CG, Jones RW
    Ref: Expert Rev Neurother, 12:1351, 2012 : PubMed


    Title: A review comparing the safety and tolerability of memantine with the acetylcholinesterase inhibitors
    Jones RW
    Ref: Int J Geriatr Psychiatry, 25:547, 2010 : PubMed


    Title: Genome sequence and analysis of the Irish potato famine pathogen Phytophthora infestans
    Haas BJ, Kamoun S, Zody MC, Jiang RH, Handsaker RE, Cano LM, Grabherr M, Kodira CD, Raffaele S and Nusbaum C <86 more author(s)>
    Ref: Nature, 461:393, 2009 : PubMed


    Title: The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics
    Jones RW, Kivipelto M, Feldman H, Sparks L, Doody R, Waters DD, Hey-Hadavi J, Breazna A, Schindler RJ, Ramos H
    Ref: Alzheimers Dement, 4:145, 2008 : PubMed


    Title: Donepezil for the treatment of agitation in Alzheimer's disease
    Howard RJ, Juszczak E, Ballard CG, Bentham P, Brown RG, Bullock R, Burns AS, Holmes C, Jacoby R and Rodger M <8 more author(s)>
    Ref: N Engl J Med, 357:1382, 2007 : PubMed


    Title: Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease
    Jones RW, Bayer A, Inglis F, Barker A, Phul R
    Ref: Int J Geriatr Psychiatry, 22:258, 2007 : PubMed


    Title: How can we best assess the quality of life of people with dementia? the Bath Assessment of Subjective Quality of Life in Dementia (BASQID)
    Trigg R, Skevington SM, Jones RW
    Ref: Gerontologist, 47:789, 2007 : PubMed


    Title: Alpha7 nicotinic acetylcholine receptor expression in Alzheimer's disease: receptor densities in brain regions of the APP(SWE) mouse model and in human peripheral blood lymphocytes
    Jones IW, Westmacott A, Chan E, Jones RW, Dineley K, O'Neill MJ, Wonnacott S
    Ref: Journal of Molecular Neuroscience, 30:83, 2006 : PubMed


    Title: Phytophthora genome sequences uncover evolutionary origins and mechanisms of pathogenesis
    Tyler BM, Tripathy S, Zhang X, Dehal P, Jiang RH, Aerts A, Arredondo FD, Baxter L, Bensasson D and Boore JL <43 more author(s)>
    Ref: Science, 313:1261, 2006 : PubMed


    Title: Have cholinergic therapies reached their clinical boundary in Alzheimer's disease?
    Jones RW
    Ref: Int J Geriatr Psychiatry, 18:S7, 2003 : PubMed


    Title: Advertisements for donepezil. Prices charged for private prescriptions for donepezil show huge variation
    Jones RW, Mann JB, Saunders SA
    Ref: BMJ, 315:1624, 1997 : PubMed


Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page

Acknowledgements and disclaimer